390 related articles for article (PubMed ID: 30953136)
1. Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
Park S; Cha YJ; Suh SH; Lee IJ; Lee KS; Hong CK; Kim JW
J Cancer Res Clin Oncol; 2019 May; 145(5):1351-1360. PubMed ID: 30953136
[TBL] [Abstract][Full Text] [Related]
2. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
[TBL] [Abstract][Full Text] [Related]
3. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
6. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
[TBL] [Abstract][Full Text] [Related]
7. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
[TBL] [Abstract][Full Text] [Related]
8. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
[TBL] [Abstract][Full Text] [Related]
9. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy alone or after subtotal resection for benign skull base meningiomas.
Mendenhall WM; Morris CG; Amdur RJ; Foote KD; Friedman WA
Cancer; 2003 Oct; 98(7):1473-82. PubMed ID: 14508835
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma.
Han J; Girvigian MR; Chen JC; Miller MJ; Lodin K; Rahimian J; Arellano A; Cahan BL; Kaptein JS
Am J Clin Oncol; 2014 Jun; 37(3):255-60. PubMed ID: 23241504
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of postoperative radiotherapy for high grade meningiomas.
Choi Y; Lim DH; Jo K; Nam DH; Seol HJ; Lee JI
J Neurooncol; 2014 Sep; 119(2):405-12. PubMed ID: 24965339
[TBL] [Abstract][Full Text] [Related]
14. Effect of dural detachment on long-term tumor control for meningiomas treated using Simpson grade IV resection.
Fukushima Y; Oya S; Nakatomi H; Shibahara J; Hanakita S; Tanaka S; Shin M; Kawai K; Fukayama M; Saito N
J Neurosurg; 2013 Dec; 119(6):1373-9. PubMed ID: 24053497
[TBL] [Abstract][Full Text] [Related]
15. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
[TBL] [Abstract][Full Text] [Related]
16. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
[TBL] [Abstract][Full Text] [Related]
17. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
18. Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy.
Yoon H; Mehta MP; Perumal K; Helenowski IB; Chappell RJ; Akture E; Lin Y; Marymont MA; Sejpal S; Parsa A; Chandler JR; Bendok BR; Rosenow J; Salamat S; Kumthekar P; Raizer JK; Baskaya MK
J Cancer Res Ther; 2015; 11(1):59-66. PubMed ID: 25879338
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
20. Meningioma of the skull base: long-term outcome after image-guided stereotactic radiotherapy.
Kaul D; Budach V; Misch M; Wiener E; Exner S; Badakhshi H
Cancer Radiother; 2014 Dec; 18(8):730-5. PubMed ID: 25307475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]